Smoking, coffee intake, and Parkinson's disease: Potential protective mechanisms and components

被引:0
|
作者
Hong, Sa Weon [1 ]
Page, Rachel [1 ]
Truman, Penelope [1 ]
机构
[1] Massey Univ, Sch Hlth Sci, Wellington 6021, New Zealand
关键词
Parkinson's disease; Smoking; Coffee drinking; Phenolic compounds; Monoamine oxidase B; Catechol O -methyltransferase; CATECHOL-O-METHYLTRANSFERASE; MONOAMINE-OXIDASE-B; 6-HYDROXYDOPAMINE RAT MODEL; NRF2 TRANSCRIPTION FACTOR; NF-KAPPA-B; ALPHA-SYNUCLEIN; CAFFEIC ACID; OXIDATIVE STRESS; FERULIC ACID; MOUSE MODEL;
D O I
10.1016/j.neuro.2024.12.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Environmental and lifestyle factors, such as smoking and coffee drinking, have been associated with a decreased risk for PD. However, the biological mechanisms underlying protective effects on PD are still not fully understood. It has been suggested that nonnicotine components in cigarette smoke and non-caffeine components in coffee may contribute to this protective effect. The aim of this review was to explore candidate molecules and mechanisms behind the effects of smoking and coffee drinking on PD by integrating findings from previous studies. By cross-referencing an index of tobacco constituents and a list of coffee constituents with existing literature on natural compounds and their structural analogs that show inhibitory activities against monoamine oxidase B, catechol O-methyltransferase, and alpha-synuclein fibrillation, we have identified tobacco and coffee components that inhibit these targets. Furthermore, tobacco and coffee components potentially play roles in suppressing neuroinflammation, activating the Nrf2 pathway as natural activators, and altering the gut microbiome. This review suggests that the phenolic compounds from tobacco and coffee investigated may contribute to the low incidence of PD in smokers and coffee drinkers, showing moderate to strong potential as therapeutic interventions. The current review suggests that multifunctional molecules found in coffee and cigarette smoke may have potential neuroprotective effects, but none of the data indicates that multifunctionality is required for these effects. This review will deepen our understanding of how smoking and coffee drinking are linked to a reduced risk of PD and will also be important in elucidating the mechanisms underlying the protective effects of smoking and coffee drinking on PD.
引用
收藏
页码:48 / 63
页数:16
相关论文
共 50 条
  • [1] The Multiple Pharmaceutical Potential of Curcumin in Parkinson's Disease
    Ji, Hong-Fang
    Shen, Liang
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) : 369 - 373
  • [2] Chalcones as Potential Ligands for the Treatment of Parkinson's Disease
    Krolicka, Ewelina
    Kiec-Kononowicz, Katarzyna
    Lazewska, Dorota
    PHARMACEUTICALS, 2022, 15 (07)
  • [3] Protective Mechanisms of Flavonoids in Parkinson's Disease
    Magalingam, Kasthuri Bai
    Radhakrishnan, Ammu Kutty
    Haleagrahara, Nagaraja
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
  • [4] Gut Feelings About Smoking and Coffee in Parkinson's Disease
    Derkinderen, Pascal
    Shannon, Kathleen M.
    Brundin, Patrik
    MOVEMENT DISORDERS, 2014, 29 (08) : 976 - 979
  • [5] Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese
    Tan, EK
    Tan, C
    Fook-Chong, SMC
    Lum, SY
    Chai, A
    Chung, H
    Shen, H
    Zhao, Y
    Teoh, ML
    Yih, Y
    Pavanni, R
    Chandran, VR
    Wong, MC
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 216 (01) : 163 - 167
  • [6] Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk
    Powers, Karen M.
    Kay, Denise M.
    Factor, Stewart A.
    Zabetian, Cyrus P.
    Higgins, Donald S.
    Samii, All
    Nutt, John G.
    Griffith, Alida
    Leis, Berta
    Roberts, John W.
    Martinez, Erica D.
    Montimurro, Jennifer S.
    Checkoway, Harvey
    Payami, Haydeh
    MOVEMENT DISORDERS, 2008, 23 (01) : 88 - 95
  • [7] Protective Microglia and Their Regulation in Parkinson's Disease
    Le, Weidong
    Wu, Junjiao
    Tang, Yu
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2016, 9
  • [8] The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease
    Kandinov, Boris
    Giladi, Nir
    Korczyn, Amos D.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 (04) : 243 - 245
  • [9] Protective and toxic roles of dopamine in Parkinson's disease
    Segura-Aguilar, Juan
    Paris, Irmgard
    Munoz, Patricia
    Ferrari, Emanuele
    Zecca, Luigi
    Zucca, Fabio A.
    JOURNAL OF NEUROCHEMISTRY, 2014, 129 (06) : 898 - 915
  • [10] c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential
    Brahmachari, Saurav
    Karuppagounder, Senthilkumar S.
    Ge, Preston
    Lee, Saebom
    Dawson, Valina L.
    Dawson, Ted M.
    Ko, Han Seok
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (04) : 589 - 601